January 08, 2013 at 12:28 PM EST
Joinn Labs of China Buys Bayer’s San Francisco-Area Campus
Joinn Laboratories, a pre-clinical CRO with facilities in Beijing and Taicang, bought the major biopharma campus in the San Francisco Bay area that formerly belonged to Bayer. Joinn, which was founded in 1995, is implementing a “go-big” strategy. It wants to offer major pharmaceutical companies the ability to work on several major projects simultaneously, minimizing the number of CRO contacts each pharma must maintain. Toward that end, Joinn is also building a 1.2 million square foot lab/office space in Taicang, in addition to its newly acquired facility in  California . More details.... Stock Symbol: (Xetra: BAY) Share this with colleagues: // //  
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
//-->